About Index Trending news
Analyze
Top 50 Pricing
Interface Biologics

Interface Biologics

Work at Interface Biologics? Add yourself to this profile

Interface Biologics

Develops transformative biomedical polymer technology to improve safety of med device. Focused on anti-thrombogenic additives and combo drug delivery devices.

Elsewhere

Alexa global traffic share

Twitter followers

08 Dec 2011
$1,000,000
Venture capital
11 Jan 2011
$7,000,000
Venture capital (Series B)
01 Jan 2010
$19,000,000
Venture capital (Series A)
09 Dec 2008
$5,000,000
Venture capital
BDC Capital Corporation, Covington Capital